A2 Biotherapeutics Overview

  • Founded
  • 2018
Founded
  • Status
  • Private
  • Employees
  • 40
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $57M
Latest Deal Amount
  • Investors
  • 5

A2 Biotherapeutics General Information

Description

Developer of a cell therapy designed to cure cancer via tumor-specific targeting. The company's therapy engineer T cells that target the loss of genetic material and the selective killing of tumor cells, enabling medical professionals to increase the effectiveness of the body's natural immune defenses.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 30301 Agoura Road
  • Suite 210
  • Agoura Hills, CA 91301
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

A2 Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 05-Nov-2019 $57M 0000 Completed Startup
1. Early Stage VC Completed Startup
To view A2 Biotherapeutics’s complete valuation and funding history, request access »

A2 Biotherapeutics Executive Team (7)

Name Title Board Seat Contact Info
Scott Foraker JD Chief Executive Officer, President & Board Member
David Lucas Chief Operating Officer
Alexander Kamb Ph.D Co-Founder, Chief Scientific Officer & Board Member
Han Xu Ph.D Director, Technology
Michael Gallo Ph.D Co-Founder & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

A2 Biotherapeutics Board Members (10)

Name Representing Role Since
Alexander Kamb Ph.D A2 Biotherapeutics Co-Founder, Chief Scientific Officer & Board Member 000 0000
David Chang MD A2 Biotherapeutics Board Member 000 0000
David Goeddel Ph.D The Column Group Board Member 000 0000
Helen Kim Self Board Member 000 0000
Jakob Loven Ph.D Nextech Invest Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

A2 Biotherapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

A2 Biotherapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Casdin Capital Hedge Fund Minority 000 0000 000000 0
Nextech Invest Venture Capital Minority 000 0000 000000 0
Samsara BioCapital Venture Capital Minority 000 0000 000000 0
The Column Group Venture Capital Minority 000 0000 000000 0
Vida Ventures (Boston) Venture Capital Minority 000 0000 000000 0
To view A2 Biotherapeutics’s complete investors history, request access »